Abbott to collaborate with Janssen Biotech and Pharmacyclics on CLL companion diagnostic
This article was originally published in Scrip
Executive Summary
Abbott is to collaborate with Janssen Biotech and Pharmacyclics on the development of a companion diagnostic test to be used with an investigational therapy for leukaemia.